Meeder Asset Management’s Amphastar Pharmaceuticals AMPH Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q4 | – | Sell |
-175
| Closed | -$5K | – | 840 |
|
|
2022
Q3 | $5K | Buy |
175
+5
| +3% | +$143 | ﹤0.01% | 1534 |
|
|
2022
Q2 | $6K | Buy |
170
+34
| +25% | +$1.2K | ﹤0.01% | 1551 |
|
|
2022
Q1 | $5K | Buy |
+136
| New | +$5K | ﹤0.01% | 1771 |
|
|
2021
Q4 | – | Sell |
-177
| Closed | -$3K | – | 1177 |
|
|
2021
Q3 | $3K | Buy |
177
+35
| +25% | +$593 | ﹤0.01% | 2052 |
|
|
2021
Q2 | $3K | Buy |
142
+8
| +6% | +$169 | ﹤0.01% | 2075 |
|
|
2021
Q1 | $2K | Buy |
134
+26
| +24% | +$388 | ﹤0.01% | 2051 |
|
|
2020
Q4 | $2K | Sell |
108
-32
| -23% | -$593 | ﹤0.01% | 1447 |
|
|
2020
Q3 | $3K | Buy |
140
+59
| +73% | +$1.26K | ﹤0.01% | 1700 |
|
|
2020
Q2 | $2K | Sell |
81
-188
| -70% | -$4.64K | ﹤0.01% | 1739 |
|
|
2020
Q1 | $4K | Sell |
269
-546
| -67% | -$8.12K | ﹤0.01% | 1842 |
|
|
2019
Q4 | $16K | Buy |
815
+82
| +11% | +$1.61K | ﹤0.01% | 1423 |
|
|
2019
Q3 | $15K | Sell |
733
-11,008
| -94% | -$225K | ﹤0.01% | 1400 |
|
|
2019
Q2 | $249K | Sell |
11,741
-3,655
| -24% | -$77.5K | 0.02% | 536 |
|
|
2019
Q1 | $315K | Buy |
15,396
+10,765
| +232% | +$220K | 0.02% | 459 |
|
|
2018
Q4 | $92K | Buy |
+4,631
| New | +$92K | 0.01% | 658 |
|
|
2018
Q3 | – | Sell |
-10,486
| Closed | -$160K | – | 1525 |
|
|
2018
Q2 | $160K | Buy |
10,486
+7,572
| +260% | +$116K | 0.01% | 538 |
|
|
2018
Q1 | $55K | Buy |
2,914
+294
| +11% | +$5.55K | 0.01% | 647 |
|
|
2017
Q4 | $50K | Buy |
2,620
+2,362
| +916% | +$45.1K | ﹤0.01% | 695 |
|
|
2017
Q3 | $5K | Sell |
258
-128
| -33% | -$2.48K | ﹤0.01% | 1253 |
|
|
2017
Q2 | $7K | Buy |
386
+189
| +96% | +$3.43K | ﹤0.01% | 1079 |
|
|
2017
Q1 | $3K | Buy |
+197
| New | +$3K | ﹤0.01% | 1238 |
|